
Demystifying Drug Discovery, Ray Stevens, CEO, Structure Therapeutics
Synopsis: In this episode of the Biotech 2050 podcast, host Rahul Chaturvedi engages in a thought-provoking conversation with Ray Stevens, a prominent figure in the biotech industry who co-founded St...
3 Apr 202431min

Navigating The Evolving Landscape of Inflammation Research, Scott Megaffin, CEO, Adiso Therapeutics
Synopsis: In this episode of Biotech2050, Scott Megaffin, CEO of Adiso Therapeutics, shares valuable insights on the challenges and opportunities in the biotech industry. His deep involvement in the ...
27 Mar 202427min

Biotech's Game Changers & Revolutionizing Therapeutics, Dr. Mammen, CEO, FogPharma
Synopsis: In this episode of the Biotech2050 podcast, Dr. Mathai Mammen, CEO of FogPharma, shares valuable insights into the future trends of the biotech industry and the development of peptide-based...
20 Mar 202450min

The Race to Cure Untreatable Cancers, Ken Galbraith, Chair and CEO, Zymeworks
Synopsis: In the recent episode of Biotech2050, Ken Galbraith, CEO of Zymeworks, shares profound insights into the biotech industry, leadership, and the complexities of developing innovative treatmen...
13 Mar 202440min

Innovation in Precision Therapies for CNS Diseases, Craig Chambliss, Co-Founder and CEO, Neurelis
Synopsis: In this episode of Biotech2050, host Alok Tayi engages in a profound conversation with Craig Chambliss, CEO and co-founder of Neurellis, delving into their strategic advancements in precisi...
6 Mar 202436min

Unlocking Genetic Medicine's Full Potential, Tuyen Ong, CEO, Ring Therapeutics
Synopsis: On the Biotech2050 podcast, Tuyen Ong, CEO at Ring Therapeutics and CEO partner at flagship pioneering, shared his journey from a medical background to leading innovative gene therapy compa...
28 Feb 202423min

Aging Biology and The Power of Human Data, Kristen Fortney, Co-Founder and CEO, BioAge
Synopsis: In a recent episode of Biotech2050, hosted by Alok Tayi, Kristen Fortney, CEO of BioAge, provides valuable insights into the evolving landscape of aging biology and the innovative approach ...
21 Feb 202426min

The Intersection Of Tech and Biotech, Chris Gibson, Co-Founder & CEO, Recursion
Synopsis: In this episode of the Biotech2050 podcast, Chris Gibson, the co-founder and CEO of Recursion, shares insights on the intersection of technology and biotech, emphasizing the importance of a...
14 Feb 202439min



















